QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

RGEN

QT74Repligen Corporation
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
132.02
-1.53-1.15%
OverviewShort InterestFilings
RGENQT74Repligen Corporation·NASDAQ
OverviewShort InterestFilings
132.02-1.15%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32AVTR+1.27%$9.58
Snapshot
Index-P/E146.43EPS (ttm)0.90
Insider Own1.14%
Shs Outstand56.41M
Perf Week-0.98%
Market Cap7.53BForward P/E51.74EPS next Y2.58Insider Trans0.00%Shs Float-Perf Month21.65%
Enterprise Value7.64BPEG0.05EPS next Q0.46Inst Own-Short Float-Perf Quarter12.25%
Income51.23MP/S9.87EPS this Y122.57%Inst Trans-Short Ratio-Perf Half Y-16.49%
Sales763.34MP/B3.57EPS next Y28.87%ROA1.75%Short Interest-Perf YTD-19.43%
Book/sh37.32P/C57.58EPS next 5Y28.39%ROE2.46%52W High175.77 -24.89%Perf Year9.10%
Cash/sh13.92P/FCF72.36EPS past 3/5Y-ROIC2.18%52W Low100.99 30.73%Perf 3Y-
Dividend Est.-EV/EBITDA44.27Sales past 3/5Y-2.73% 15.06%Gross Margin50.25%Volatility2.95% 3.38%Perf 5Y-
Dividend TTM-EV/Sales10.01EPS Y/Y TTM491.30%Oper. Margin8.81%ATR (14)5.84Perf 10Y-
Dividend Ex-Date-Quick Ratio7.78Sales Y/Y TTM20.35%Profit Margin6.73%RSI (14)61.59Recom2.22
Dividend Gr. 3/5Y-Current Ratio9.20EPS Q/Q23.08%SMA205.76%Beta1.37Target Price158.67
Payout0.00%Debt/Eq0.33Sales Q/Q14.79%SMA508.71%Rel Volume1.08Prev Close133.55
Employees1,778LT Debt/Eq0.32EarningsAug 04SMA200-4.47%Avg Volume1.15MPrice132.02
IPO DateApr 29, 1986Option/ShortYes / YesEPS/Sales Surpr.26.32% 1.04%Net Debt/EBITDA0.61Volume1,236,919Change-1.15%
Analyst Ratings
DateActionAnalystRatingTarget
May-14-26ResumedRBC CapitalOutperform$205 → $160
May-05-26ReiteratedJefferiesHold$152 → $142
Apr-20-26ReiteratedCanaccord GenuityHold$165 → $145
Apr-17-26InitiatedRothschild & Co RedburnBuy$160
Apr-14-26ReiteratedBarclaysOverweight$200 → $145
Jan-16-26ReiteratedUBSBuy$185 → $200
Dec-15-25ReiteratedWells FargoOverweight$190
Dec-15-25ReiteratedBarclaysOverweight$175 → $200
Oct-29-25ReiteratedBarclaysOverweight$160 → $175
Oct-29-25ReiteratedCanaccord GenuityHold$165
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue763738634
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A379391360
Gross Profit383348275
Selling, General and Administrative Excl. Other285291263
Research and Development545443
Other Operating Expense-23-574
Operating Income6860-35
Interest Expense452323
Unusual Expense
———
Non-Operating Income (Expense)-12-26-29
Net Income Before Taxes5662-27
Income Taxes413-2
Consolidated Net Income5149-26
Net Income From Continuing Operations5149-26
Net Income5149-26
EPS (Recurring)0.910.87-0.46
EPS (Basic, Before Extraordinaries)0.910.87-0.46
EPS (Diluted)0.900.86-0.46
EBITDA17216480
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio146.69190.53—
Price To Sales Ratio9.6912.43—
Gross Margin50.2047.1543.38
Operating Margin8.918.13-5.52
Net Margin6.686.64-4.10
Shares Outstanding565656
Market Capitalization7,3939,176—
Operating Lease Expense
———
Insider Trading Volume
$139.69$128.41$117.13$105.84$94.56● Close Price0.00M2.14M4.27M6.41M8.54MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MUIR GLENN PDirectorMay 07 '26Option Exercise38.764,868188,68439,056May 08 12:00 AM
Loeillot OlivierChief Executive OfficerApr 21 '26Sale140.003,832536,48054,246Apr 22 12:00 AM
DAWES KAREN ADirectorDec 17 '25Sale161.0027544,27591,821Dec 18 12:00 AM
MUIR GLENN PDirectorDec 16 '25Option Exercise26.126,732175,84036,622Dec 17 12:00 AM
Loeillot OlivierChief Executive OfficerNov 25 '25Sale170.007,0411,196,97035,898Nov 26 12:00 AM
Bylund JamesChief Operating OfficerNov 18 '25Sale151.212,191331,30121,520Nov 19 12:00 AM
Hunt AnthonyDirectorNov 13 '25Sale154.6120,0003,092,27880,743Nov 14 12:00 AM
Hunt AnthonyDirectorNov 13 '25Option Exercise33.875,904199,96883,695Nov 14 12:00 AM
Hunt AnthonyDirectorNov 12 '25Sale156.8825,0003,921,940100,743Nov 13 12:00 AM
Hunt AnthonyDirectorNov 12 '25Option Exercise33.8750,0001,693,500157,344Nov 13 12:00 AM
Hunt AnthonyDirectorSep 10 '25Sale120.5229,1113,508,390100,743Sep 11 12:00 AM
Hunt AnthonyDirectorSep 10 '25Option Exercise33.8740,0001,354,800182,344Sep 11 12:00 AM
Madaus Martin DDirectorAug 08 '25Buy112.131,800201,8301,800Aug 12 12:00 AM
Hunt AnthonyDirectorMay 15 '25Sale123.7126,4473,271,688109,854May 16 12:00 AM
Hunt AnthonyDirectorMar 17 '25Option Exercise54.7353,5122,928,534202,344Mar 19 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR